Portfolio company
Limula
Switzerland · £6.2m raised
Raised
£6.2m
Latest stage
Seed
Rounds recorded
1
Backed by
5 investors
Sectors
About
Limula develops an automated platform for manufacturing cell and gene therapies to assist therapy developers, hospitals and clinical centres with decentralized production.
SourceFunding history · 1
Similar companies
Cellular Origins
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Biothrust
This company develops bionic bioreactors for bubble-free cell cultivation to enable scalable manufacturing for pharmaceutical firms, research institutions and therapy developers.
Sarcura
This company develops automated platforms for large-scale manufacturing of personalised cell therapies for the biopharmaceutical industry.
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
Anaula
Anaula builds autonomous bioreactors to manage infrastructure and human error in biological and pharmaceutical manufacturing for life sciences and drug development companies.
MFX
This company develops automated microfluidic bioreactor platforms and data generation infrastructure for researchers and manufacturers in the cell and gene therapy sector.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
